Early Pharmaceutical Treatment Modalities for COVID-19 Patients in the Beginning of the Pandemic
Abstract Coronavirus is a family of RNA viruses that come from the genus beta coronavirus, this virus is distributed in many species like, birds, humans and other mammals. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. In most infected people with COVID-19 virus, the symptoms will appear as mild to moderate respiratory, symptoms and most of them can recover without needing specific treatment. On the other hand, older people and those with fundamental medical, problems such as, cardiovascular disease, diabetes, chronic respiratory disease and cancer are more likely to develop a serious illness and require special care and treatment.
Authors
- Bashaer M. Muhammad-Baqir
- Zahraa Fathi Sharba (ORCID: https://orcid.org/0000-0002-3800-9225)
- Wadhah Abdulhussian Mahbuba
- Rawaa Hadi Shareef
Institutions
- University of Kufa (IQ)
Publication Details
- Journal
- Medical Journal of Babylon
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/mjbl.mjbl_845_23
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.79